logo
Home  > Inhibitors/Agonists  > Metabolic Enzyme  > P450  > Seratrodast

AD63590

112665-43-7 | Seratrodast

Packsize Purity Availability Price Discounted Price    Quantity
10mg 98% in stock $57.00 $40.00 -   +
100mg 98% in stock $78.00 $54.00 -   +
250mg 98% in stock $155.00 $108.00 -   +
1g 98% in stock $387.00 $271.00 -   +

*All products are for research use only and not intended for human or animal use.

*All prices are in USD.

Description
Catalog Number: AD63590
Chemical Name: Seratrodast
CAS Number: 112665-43-7
Molecular Formula: C22H26O4
Molecular Weight: 354.4394
MDL Number: MFCD00875701
SMILES: OC(=O)CCCCCC(C1=C(C)C(=O)C(=C(C1=O)C)C)c1ccccc1
NSC Number: 759640

 

Computed Properties
Complexity: 633  
Covalently-Bonded Unit Count: 1  
Heavy Atom Count: 26  
Hydrogen Bond Acceptor Count: 4  
Hydrogen Bond Donor Count: 1  
Rotatable Bond Count: 8  
Undefined Atom Stereocenter Count: 1  
XLogP3: 4.4  

 

 

Upstream Synthesis Route
  • Seratrodast, a potent thromboxane A2 receptor antagonist, finds a valuable application in chemical synthesis as a versatile building block for the preparation of various pharmaceutical compounds. Its unique structural features and pharmacological properties make it a key intermediate in the synthesis of novel drug candidates targeting inflammation, asthma, and other related conditions. By incorporating Seratrodast into synthetic pathways, chemists can access a diverse array of derivatives with tailored activities and improved pharmacokinetic profiles. Moreover, its selective inhibition of specific biochemical pathways offers opportunities for designing more effective and safer therapeutics. Through strategic utilization of Seratrodast in chemical synthesis, researchers can accelerate the discovery and development of innovative drugs for a wide range of medical applications.
FEATURED PRODUCTS